
BioNJ Manufacturing Briefing 2024:
Key Biopharma Insights
Shaping Tomorrow: Trends in Biopharmaceutical Manufacturing & FDA Innovations We recently attended an insightful seminar on biotech manufacturing that we’d

Shaping Tomorrow: Trends in Biopharmaceutical Manufacturing & FDA Innovations We recently attended an insightful seminar on biotech manufacturing that we’d

Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.
A new investigational therapy from Celldex Therapeutics Inc. in Hampton, New Jersey provides the promise of substantial relief from “hives”,

The Impact of Real-World Evidence (RWE) on Drug Testing & FDA Approval The landscape of drug development is undergoing a

There’s no stopping Mother Nature when she gets going. The striking force of a tornado recently tore through a Pfizer

According to the National Institutes of Health (NIH), there are over 7,000 diseases classified as rare, affecting an estimated 25-30 million Americans.

What You Need to Know to Get Approved Bringing a new drug therapy or medical device to market is a

No business wants unexpected liabilities. People across the country are returning to work in high-contact and other industries. It’s not